SEMIRARA Mining and Power Corp. (SMPC) expects to receive clearance from the Department of Environment and Natural Resources (DENR) for its mine site in Antique in the second half of the year, ...

Herceptin with chemotherapy improved OS and PFS in HER2-positive gastric cancers, but benefits decreased after chemotherapy regimen changes. Major pathological response rates were higher with ...

INTERNET, Everywhere / George Town, Cayman Islands--(BUSINESS WIRE)--The Worldcoin Foundation today announced it launched and is open sourcing a novel secure multi-party computation (SMPC) system. The ...

When you or a loved one has breast cancer, your doctor will figure out the best treatment options to offer you based on your particular tumor, your age, other conditions you have, and your wishes.

Has the promise of biosimilars been fulfilled? Authors of a case study appearing in this month’s edition of Health Affairs call it “the best example to date” that biosimilars can successfully bring ...

A recent study provided new evidence about the effect that the entry of biosimilars has on lowering the price of cancer treatments covered by Medicare. The study, published in the Journal of Clinical ...

Phesgo® Can be Administered in 5 to 8 Minutes Compared with Hours for the Standard Sequential IV Administration of Perjeta® and Herceptin® Phesgo® Can be Administered in 5 to 8 Minutes Compared with ...

Mylan N.V. MYL and partner Biocon Ltd. announced the launch of Ogivri (trastuzumab-dkst), a biosimilar of Roche’s RHHBY blockbuster breast cancer drug, Herceptin (trastuzumab), in the United States.